Literature DB >> 11469471

Pigmented villonodular synovitis. Review of 20 cases.

H R Dürr1, A Stäbler, M Maier, H J Refior.   

Abstract

OBJECTIVE: Pigmented villonodular synovitis (PVS) is a rare aggressive lesion. Inclusion of this disease in the differential diagnosis of rheumatoid arthritis can lead to early diagnosis and treatment. In this retrospective study we evaluated diagnostic procedures, therapies, and outcomes of PVS.
METHODS: Twenty surgically treated cases of PVS were evaluated: joint, 16; tenosynovial, 3; and bursa, one. The 20 patients had undergone the following surgeries: 4 total synovectomies, 2 subtotal synovectomies, eight arthroscopically assisted resections, 4 resections of extraarticular lesions, and 2 arthroplasties. The mean followup was 17.5 mo (1-54).
RESULTS: At diagnosis, pain was present in 19 of 20 cases. Joint swelling or a tumor was found in 11 cases, and 12 patients complained of repeated joint effusions. The mean duration of symptoms was 23.8 mo (range 1-144). Half the cases had a nodular pattern and the other half a diffuse pattern. The most common location of PVS was the knee (14 patients). Surgical treatment before admission did not always lead to an accurate diagnosis. For example, in 2 patients, arthroscopy did not reveal PVS. In 2 patients a soft tissue sarcoma was suggested. In 3 patients, the diagnosis was made incidentally with arthroscopy or arthroplasty. On radiographs, bone lesions were seen in 8 cases; in 13 of 17 cases the diagnosis was by magnetic resonance imaging (MRI). After surgery 17 patients stayed free of recurrence, 14 without symptoms. One patient who had an incidental diagnosis of PVS has a synovectomy planned as a second procedure. One patient awaits a second dorsal procedure after a ventral knee synovectomy. One patient shows recurrent disease 33 mo after resection of a nodular knee lesion.
CONCLUSION: PVS should be included in the differential diagnosis of any arthritis. MRI is the most effective diagnostic tool in identifying PVS. The treatment of PVS consists of surgical excision in sound tissue. A total synovectomy should be the treatment of choice in diffuse disease. From the literature, nonsurgical therapies, such as steroid injections, 90Y synoviorthesis, or external beam radiation, seem to be of benefit in selected patients.

Entities:  

Mesh:

Year:  2001        PMID: 11469471

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  [Pigmented villonodular synovitis of the knee joint].

Authors:  P Jungbluth; K F Hopf; M Wick; H Homann; T Kagel; C Kuhnen; G Muhr; T Kälicke
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

Review 2.  [Diagnosis and therapy of benign intraarticular tumors].

Authors:  H R Dürr; A Klein
Journal:  Orthopade       Date:  2017-06       Impact factor: 1.087

3.  Pediatric pigmented villonodular synovitis mimicking a septic hip.

Authors:  Aarat M Patel; Amanda G Brown; Csaba Galambos; Raphael Hirsch
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

4.  Pigmented villonodular synovitis of the elbow.

Authors:  J Terrence Jose Jerome; Balu Sankaran
Journal:  Indian J Pediatr       Date:  2009-02-10       Impact factor: 1.967

5.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

6.  Surgery on aggressive fibroma of the posterior compartment of the knee: A case report.

Authors:  R M S N Magetsari; M N S Irawan
Journal:  Int J Surg Case Rep       Date:  2019-11-06

7.  Acute Knee Pain in a Child Due to Pigmented Villonodular Synovitis.

Authors:  Cheung Man Hong; Lui Tun Hing
Journal:  J Orthop Case Rep       Date:  2015 Jul-Sep

Review 8.  Soft tissue tumours of the elbow: current concepts.

Authors:  Olga D Savvidou; Panagiotis Koutsouradis; Ioanna K Bolia; Angelos Kaspiris; George D Chloros; Panayiotis J Papagelopoulos
Journal:  EFORT Open Rev       Date:  2020-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.